T

Tenri Hospital | Clinical Trial Support Office

Research site

(Unclaimed)

Location

200　Mishimacho Tenri-Shi Nara, Tenri, Nara, Japan

Site insights

Top conditions

Top treatments

Quizartinib

Copanlisib

INCB050465

Tegafur-Uracil

Nipocalimab

Bosentan

Parsaclisib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 15 total trials

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

The main purpose of this study is to evaluate the safety and efficacy of nipocalimab compared to placebo in delaying relapse in adults with chronic i...

Enrolling

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Drug: Nipocalimab

Drug: Placebo

Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML (QuANTUM-WILD)

This study will compare the effects of Quizartinib versus placebo in combination with chemotherapy in participants with newly diagnosed FMS-like tyro...

Enrolling

Leukemia

Drug: Quizartinib

Drug: Placebo

Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465)

This is a Phase 2, multicenter, open-label study to provide continued supply of parsaclisib as monotherapy or in combination therapy with itacitinib,...

Active, not recruiting

B-Cell Malignancies

Drug: parsaclisib + itacitinib

Drug: parsaclisib + ruxolitinib